FDA Orders GLP-1 Companies to Add Warning of Vision Loss Risk

  • Now Playing

    FDA Orders Warning Label on GLP-1s for Risk of Eye Condition

    00:39

  • UP NEXT

    How Parents Can Give Themselves Grace During the Holidays

    03:46

  • NBC’s Chloe Melas Opens Up About Journey With IBD

    05:19

  • New Weight Loss Drug Could Also Treat Knee Arthritis: Study

    04:31

  • Chloe Melas on New Book ‘The Girl’s Guide to Guts’

    04:30

  • U.S. Could Lose Measles Elimination Status as Cases Surge

    01:43

  • Which Viral Skin Care Ingredients Are Worth it and Which to Skip

    04:02

  • CVS Health Plans to Split Into Two Separate Companies

    00:19

  • How Rising Rates and Policy Changes May Impact Your Insurance

    05:44

  • Some Babies Born With Peanut Allergy Could Grow Out of it: Study

    03:35

  • Which Foods Are Best for Boosting Brain Health?

    05:08

  • Spotlight on Men’s Health: Plunges, Testosterone Therapy, More

    05:59

  • Rebecca Gayheart Opens Up About Eric Dane’s Life and Legacy

    05:52

  • Get Your Steps in This Fall With Start TODAY’s November Plan

    05:37

  • Flu Season Kicks off Early: Is it Too Late to Get the Vaccine?

    03:20

  • How Healthy Habits in Middle Age May Ward Off Alzheimer’s

    08:00

  • Katie Couric Televises Her Colonoscopy on TODAY in 2000

    09:14

  • Pat Croce Shares Lessons From ‘Enjoy Yourself Now!’

    04:41

  • Clocks Change This Weekend: What You Can Do Now to Adjust

    04:17

  • Health Concerns Raised for Elementary School Near Data Centers

    03:33

The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare eye condition that may cause permanent vision loss.

Source link